When applying radiation therapy, accuracy is key. DoseVue provides in-vivo dosimetry solutions through easy-to-use radiation measurement devices.
The vital importance of dosimetry
In oncology, radiation therapy is used to eliminate or shrink tumors. Delivering the correct radiation dose is vital: too much radiation can cause damage to the surrounding healthy tissues, whereas too low a dose may fail to kill the malignant cells.
In-vivo dosimetry can be used during procedures to detect the exact amount of radiation being delivered to the patient. However, there has long been a lack of practical, effective and accurate in- vivo dosimetry tools.
DoseVue’s improved in-vivo dosimetry solutions enhance the quality of radiation therapy.
Improve patient outcomes with in-vivo dosimetry
Get in touchInnovative solutions for
better cancer treatments
DoseVue’s unique technology uses thin fiber optic filaments equipped with submillimeter sensors that fluoresce when exposed to radiation. Our solutions can be used for a range of applications, including intraoperative radiation therapy (IORT) and brachytherapy. Benefits include:
Easy to use, quick to implement and readily integrated in the existing clinical workflow.
Real-time measurements of cumulative dose and dose rates.
High sensitivity, with a minimal detectible dose rate of 1mGy/s.
Small and easily positioned at up to four locations on/in the patient.
Our products
DoseVue’s dosimetry solutions give real-time insights into patient treatments at each step of the way, providing accurate information on delivered dose every time and enabling adaptability of the treatment.
DoseWire™ Series
DoseWire™ Series 200 is an easy-to-use in-vivo dosimetry device. The compact optical fiber sensors can be easily positioned at up to four locations during procedures, applied on patient’s skin or introduced in natural and/or surgical cavities. It is CE-marked and can be used for a range of oncology applications, including brachytherapy and IORT.
R&D activities
DoseVue is constantly working together with academic and industry partners to expand our product range, explore additional applications for the DoseWire and develop new in-vivo dosimetry solutions.
Find out how our solutions can benefit you
Start a conversationAbout DoseVue
DoseVue was founded in 2013 as the first spin-off of the Belgian Nuclear Research Center (SCK•CEN). Our experienced management team and board of directors are supported by our dedicated investors and scientific advisors.
Latest News
Diepenbeek, Belgium - January 28, 2021 - DoseVue NV, a privately held medical device company developing in-vivo dosimetry solutions for radiation therapy, today announces the CE marking of its first…
